1. 1133PDA phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC). (23rd October 2018) Authors: Hidalgo, M; Epelbaum, R; Wolpin, B M; Stemmer, S M; Geva, R; Golan, T; Borazanci, E; Borad, M; Pedersen, K S; Park, J O; Ramirez, R; Peled, A; Lustig, T M; Bohana Kashtan, O; Rosenfeld, O; Sorani, E; Schlienger, K; Vainstein Haras, A; Von Hoff, D D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗